(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.80%) $83.18
(1.04%) $1.943
(-0.37%) $2 338.50
(-0.05%) $27.52
(0.61%) $927.70
(-0.25%) $0.932
(-0.27%) $11.00
(-0.31%) $0.798
(0.25%) $92.11
0.05% INR 328.75
Live Chart Being Loaded With Signals
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP...
Stats | |
---|---|
Tagesvolumen | 32 538.00 |
Durchschnittsvolumen | 100 381 |
Marktkapitalisierung | 30.30B |
EPS | INR0 ( 2024-01-23 ) |
Nächstes Ertragsdatum | ( INR2.80 ) 2024-05-21 |
Last Dividend | INR2.25 ( 2023-09-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 29.86 |
ATR14 | INR0.777 (0.24%) |
Volumen Korrelation
Indoco Remedies Limited Korrelation
10 Am meisten positiv korreliert | |
---|---|
ICICIGI.NS | 0.898 |
RADIOCITY.NS | 0.889 |
INSECTICID.NS | 0.883 |
INDUSTOWER.NS | 0.881 |
HDFCAMC.NS | 0.878 |
SAREGAMA.NS | 0.876 |
IDEA.NS | 0.874 |
PUNJABCHEM.NS | 0.869 |
SHOPERSTOP.NS | 0.866 |
TCIFINANCE.NS | 0.865 |
10 Am meisten negativ korreliert | |
---|---|
SICAGEN.NS | -0.883 |
SMLT.NS | -0.881 |
OIL.NS | -0.875 |
STAMPEDE.NS | -0.873 |
STERTOOLS.NS | -0.871 |
NEWGEN.NS | -0.871 |
KEERTI.NS | -0.869 |
SURYAROSNI.NS | -0.863 |
ROTO.NS | -0.862 |
PDSMFL.NS | -0.856 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Indoco Remedies Limited Korrelation - Währung/Rohstoff
Indoco Remedies Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR16.40B |
Bruttogewinn: | INR11.19B (68.21 %) |
EPS: | INR15.44 |
FY | 2022 |
Umsatz: | INR16.40B |
Bruttogewinn: | INR11.19B (68.21 %) |
EPS: | INR15.44 |
FY | 2022 |
Umsatz: | INR15.04B |
Bruttogewinn: | INR10.40B (69.16 %) |
EPS: | INR16.80 |
FY | 2021 |
Umsatz: | INR12.19B |
Bruttogewinn: | INR8.59B (70.49 %) |
EPS: | INR10.10 |
Financial Reports:
No articles found.
Indoco Remedies Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0.750 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR2.25 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.667 | 2005-09-15 |
Last Dividend | INR2.25 | 2023-09-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | INR20.23 | -- |
Avg. Dividend % Per Year | 0.26% | -- |
Score | 1.79 | -- |
Div. Sustainability Score | 2.93 | |
Div.Growth Potential Score | 3.59 | |
Div. Directional Score | 3.26 | -- |
Year | Amount | Yield |
---|---|---|
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.000 | 0.52% |
2019 | INR0.300 | 0.14% |
2020 | INR0.300 | 0.16% |
2021 | INR1.500 | 0.49% |
2022 | INR0.750 | 0.17% |
2023 | INR2.25 | 0.55% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TOUCHWOOD.NS | Dividend Junior | 2023-09-22 | Annually | 6 | 0.15% | |
PGIL.NS | Dividend Junior | 2023-09-01 | Annually | 17 | 1.08% | |
JINDALSAW.NS | Dividend Junior | 2023-06-13 | Annually | 22 | 1.62% | |
DEEPAKNTR.NS | Dividend Junior | 2023-07-27 | Annually | 14 | 0.25% | |
SKMEGGPROD.NS | Dividend Junior | 2023-08-30 | Sporadic | 21 | 0.95% | |
MGEL.NS | Dividend Junior | 2023-08-08 | Annually | 5 | 0.59% | |
HARSHA.NS | Dividend Junior | 2023-09-20 | Insufficient data to determine frequency | 2 | 0.09% | |
BDL.NS | Dividend Junior | 2023-09-20 | Semi-Annually | 7 | 1.17% | |
PTC.NS | Dividend Knight | 2023-09-20 | Annually | 21 | 6.06% | |
KDDL.NS | Dividend Junior | 2023-09-22 | Annually | 8 | 0.29% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0571 | 1.500 | 8.86 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0969 | 1.500 | -0.0350 | -0.0524 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 5.33 | 1.000 | 9.14 | 9.14 | [3 - 30] |
operatingCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 14.32 | 2.00 | 2.84 | 5.68 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.691 | 1.000 | 1.820 | 1.820 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.104 | 1.000 | 9.92 | 9.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 29.81 | 1.000 | 7.09 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0969 | 2.50 | -0.0225 | -0.0524 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 5.68 | [0 - 30] |
dividendYielPercentageTTM | 0.685 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.449 | 1.500 | -0.338 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0742 | 1.000 | -0.645 | 0 | [0.1 - 0.5] |
Total Score | 3.59 |
Indoco Remedies Limited
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.